RadNet Inc

Healthcare · Diagnostics & Research

70.80$ -0.7% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Income Statement

RadNet Inc (RDNT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 623 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement RDNT
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	LTM
Revenue	225	225	229	230	228	236	231	244	242	257	272	289	293	301	282	191	292	308	315	334	333	333	342	354	350	384	391	404	402	420	432	460	461	477	471	498	523	548	576	623	2,269
Cost of Revenue	193	192	205	199	198	200	216	210	209	233	243	247	254	256	267	194	246	258	282	284	273	285	315	306	314	330	352	345	342	357	388	390	392	411	453	429	450	472	592	535	2,049
Gross Profit	32	33	24	31	29	35	16	34	34	24	28	43	38	45	14	-3.7	45	50	33	50	60	48	27	49	36	54	39	59	60	64	44	70	69	66	18	69	72	76	-16	88	220
Research & Development	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	1.3	3.3	3.3	–	6.6	3.6	–	3.6	3.6	–	–	–
Selling, General & Administrative	2.2	0.3	0.2	0.2	1.2	0.3	0.7	0.3	0.1	1.1	244	247	254	256	268	195	247	261	283	284	273	285	315	306	314	330	352	347	–	–	–	–	–	–	–	–	–	–	–	–	–
Total Operating Expenses	17	17	17	17	17	16	18	18	17	19	20	20	20	21	23	-3.8	22	29	15	23	27	44	28	29	29	33	32	34	17	39	33	35	35	41	42	38	40	41	47	49	176
Operating Income	12	15	6.7	14	11	18	-0.9	16	16	-0.5	7.3	22	17	24	-8.8	0.2	23	21	18	28	33	4.7	-1.7	20	6.9	22	6.7	24	43	24	11	35	34	25	-24	31	33	35	-16	39	91
Interest Expense	11	11	10	10	10	9.9	10	11	11	12	12	12	12	11	12	11	11	12	13	12	12	4.3	12	11	12	15	16	16	16	17	16	26	19	18	17	17	17	18	18	18	71
Pre-Tax Income	3.4	6.0	-1.3	9.1	5.0	14	-8.0	9.0	8.6	29	-3.2	11	6.9	15	-18	-13	14	17	18	11	26	3.3	9.9	17	8.6	7.2	-13	14	31	6.7	3.5	9.4	17	15	-33	24	20	21	-33	27	35
Income Tax Expense	1.5	1.9	-0.5	3.5	1.1	20	-2.5	2.5	2.8	-2.4	-1.2	3.0	1.8	2.7	-4.4	-4.5	3.8	5.9	4.4	2.9	5.3	2.0	1.5	3.4	2.2	2.3	1.1	-0.6	7.2	0.7	-1.9	2.5	4.3	1.1	-3.4	0.8	6.4	11	-8.1	6.4	16
Net Income	1.6	3.7	-1.2	5.3	3.2	-7.3	-7.3	5.4	5.0	29	-3.7	4.9	3.2	10	-16	-11	6.2	6.0	9.5	2.9	16	-3.8	3.0	7.9	0.7	-0.9	-21	8.4	18	-1.9	-2.8	-3.0	3.2	5.3	-38	14	5.4	-0.6	-33	7.5	-21
EBITDA	32	34	24	31	29	35	16	34	34	24	45	60	56	64	32	36	63	69	71	66	82	59	65	75	68	71	50	78	80	70	52	70	71	66	20	77	77	140	30	90	337

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings